SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-17-008894
Filing Date
2017-08-17
Accepted
2017-08-17 17:00:24
Documents
3
Period of Report
2017-08-17

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k081717_biondvax.htm 6-K 14231
2 PRESS RELEASE, DATED AUGUST 14, 2017 f6k081717ex99-1_biondvax.htm EX-99.1 15300
3 GRAPHIC ex99_001.jpg GRAPHIC 14719
  Complete submission text file 0001213900-17-008894.txt   50929
Mailing Address 14 EINSTEIN ST. NES-ZIONA L3 74036
Business Address 14 EINSTEIN ST. NES-ZIONA L3 74036 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1213
Type: 6-K | Act: 34 | File No.: 001-37353 | Film No.: 171039234
SIC: 2836 Biological Products, (No Diagnostic Substances)